发明授权
US08465767B2 Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
失效
吡啶-2-基甲基亚磺酰基-1H-苯并咪唑的口服给药形式
- 专利标题: Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
- 专利标题(中): 吡啶-2-基甲基亚磺酰基-1H-苯并咪唑的口服给药形式
-
申请号: US12153585申请日: 2008-05-21
-
公开(公告)号: US08465767B2公开(公告)日: 2013-06-18
- 发明人: Rango Dietrich , Hartmut Ney
- 申请人: Rango Dietrich , Hartmut Ney
- 申请人地址: DE Constance
- 专利权人: Takeda GmbH
- 当前专利权人: Takeda GmbH
- 当前专利权人地址: DE Constance
- 代理机构: Nath, Goldberg & Meyer
- 代理商 Joshua B. Goldberg; Sheldon M. McGee
- 优先权: EP98115141 19980812
- 主分类号: A61K9/58
- IPC分类号: A61K9/58 ; A61K9/54 ; A61K31/4439
摘要:
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.